Form 8-K dated October 21, 2003

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 21, 2003

 

 

CELL THERAPEUTICS, INC.

(Exact name of Registrant as specified in its charter)

 

Washington   0-28386   91-1533912

(State or other jurisdiction of

incorporation or organization)

   (Commission File Number)  

(I.R.S. Employer

Identification Number)

 

501 Elliott Avenue West, Suite 400

Seattle, WA 98119

(Address of principal executive offices) (Zip Code)

 

(206) 282-7100

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Item 7.   Financial Statements and Exhibits.

 

(c) Exhibits.

 

Exhibit
   

Description

99.1

    Press release of Cell Therapeutics, Inc. issued on October 21, 2003.

 

Item 12.   Results of Operations and Financial Condition

 

     Information Furnished Under Item 12 of Form 8-K

 

On October 21, 2003, Cell Therapeutics, Inc. (the “Company” or the “Registrant”) issued a press release announcing results for the fiscal quarter ended September 30, 2003. The full text of the press release is set forth in Exhibit 99.1 hereto. Pursuant to General Instruction B.6 of Form 8-K, the information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

 

-2-

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

       

CELL THERAPEUTICS, INC.

a Washington corporation

October 20, 2003

      

By:

   /s/ Louis A. Bianco
         
           

Louis A. Bianco

Executive Vice President, Finance and Administration

 

-3-

Index to Exhibits

 

Exhibit
   

Description

99.1

    Press release of Cell Therapeutics, Inc. issued on October 21, 2003.